TL;DR
This study investigated whether routine in-hospital blood pressure (BP) measurements could effectively screen for hypertension in adult patients. The findings suggest that while in-hospital BP is an imperfect standalone diagnostic tool, it can serve as a valuable trigger for further community-based BP assessment, potentially identifying a significant number of undiagnosed cases.
What Problem Does This Paper Address?
Hypertension is a major global health risk, and a substantial portion of individuals with undiagnosed hypertension are found among hospital inpatients. Despite routine BP measurements during hospital stays, current international guidelines lack specific thresholds for diagnosing hypertension within this setting. This creates a missed opportunity to identify and manage hypertension early. Clinicians may hesitate to act on elevated in-hospital BP readings due to concerns about temporary elevations caused by pain, anxiety, or "white coat syndrome." However, evidence suggests that a significant percentage of patients with elevated in-hospital BP actually have sustained hypertension when assessed later in the community. This study aims to bridge this gap by evaluating the diagnostic accuracy of current UK community BP thresholds for screening hypertension in hospitalized adults.
Methods
The study employed a prospective diagnostic accuracy design, conducted across three UK National Health Service (NHS) hospital trusts. An automated algorithm was developed to screen electronic patient records for potentially eligible patients based on BP measurements, diagnostic codes, and prescribed medications. Eligible patients, defined by specific in-hospital BP ranges and without a prior hypertension diagnosis, were approached. The "index test" was the cumulative mean in-hospital daytime BP, measured as part of routine clinical care. The "reference standard" was 24-hour ambulatory blood pressure monitoring (ABPM) conducted in the community 4-26 weeks post-discharge, using established UK diagnostic thresholds. The study also explored the accuracy of various alternative in-hospital BP thresholds. Statistical analysis focused on sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Receiver Operator Characteristic (ROC) curves were used to assess the discriminatory power of different thresholds.
Datasets
The study utilized routinely collected electronic patient records from three UK NHS hospital trusts for initial screening. The primary dataset for evaluation comprised 24-hour ambulatory blood pressure monitoring (ABPM) data collected from participants in the community post-discharge. This ABPM data served as the reference standard for diagnosing hypertension.
Key Insights and Ideas
- In-hospital BP as a Trigger, Not a Diagnosis: The study strongly suggests that while in-hospital BP measurements alone are not sufficient for a definitive hypertension diagnosis, they are valuable for identifying patients who require further assessment in the community.
- Significant Undiagnosed Hypertension in Hospitals: A substantial proportion of hospitalized patients (44% overall, and 55% of those with raised in-hospital BP) were found to have community-diagnosed hypertension.
- Potential for Digital Screening: The use of an automated algorithm to screen electronic health records represents a novel and efficient method for identifying potential cases within a hospital setting.
- Night-time Hypertension is Common: A notable percentage of patients (23%) exhibited isolated night-time hypertension, highlighting the importance of considering this aspect of BP monitoring.
Key Results
- Out of 17,849 patients initially screened, 351 were recruited, and 206 completed the study protocol with ABPM data.
- Of the 206 participants who completed ABPM, 91 (44%) had daytime community hypertension.
- For the primary index test (in-hospital daytime BP ≥135 mm Hg systolic or ≥85 mm Hg diastolic), the sensitivity for detecting daytime community hypertension was 65% and the specificity was 58%.
- The positive predictive value (PPV) was 55%, and the negative predictive value (NPV) was 68%.
- When considering both daytime and night-time community hypertension, the sensitivity was 62% and specificity was 68%, with a PPV of 79% and NPV of 48%.
- No adverse events were reported during the study.
Limitations and Future Work
The authors acknowledge a notable difference between the number of participants recruited and those who completed reference testing, partly due to the suspension of recruitment and follow-up during the COVID-19 pandemic. This led to a larger-than-anticipated number of participants not completing ABPM, preventing imputation of results. The study also had limited representation from non-white ethnic groups, suggesting a need for external validation in more diverse cohorts. Future research should focus on externally validating these findings, exploring the predictive performance of thresholds in broader populations, and investigating the optimal balance between sensitivity and specificity for in-hospital screening thresholds, considering clinical acceptability and resource implications. The study also suggests that antihypertensive treatment might be more safely initiated in primary care after further evaluation, rather than acutely in hospital.
Summary updated